Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 1 SUPPL. 1, 2006, Pages

  Regev, Arie ^a   Guaqueta, Constanza ^a   Molina, Enrique G ^a   Conrad, Andrew ^b   Mishra, Vishnu ^c   Brantly, Mark L ^c   Torres, Maria ^a   De Medina, Maria ^a   Tzakis, Andreas G ^a   Schiff, Eugene R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b National Genetics Institute   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alpha 1 antitrypsin deficiency; Chronic liver disease; Gene modifiers

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CASE CONTROL STUDY; CHRONIC LIVER DISEASE; DISEASE SEVERITY; ENZYME DEFICIENCY; FEMALE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FLORIDA; GENE FREQUENCY; HEPACIVIRUS; HETEROZYGOTE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; SEVERITY OF ILLNESS INDEX;

HEPATITIS C VIRUS;

EID: 33745764351     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000226387.56612.1e     Document Type: Article

References (25)

1. Perlmutter D. α1-Antitrypsin Deficiency. In: Schiff E, Sorrell M, Maddrey W, eds. Schiff's Diseases of the Liver, 9th. Philadelphia: Lippincott Williams & Wilkins, 2003:1207-29.
2. Fisher RL, Taylor L, Sherlock S. Alpha-1-antitrypsin deficiency in liver disease: the extent of the problem. Gastroenterology 1976;71:646-51.
3. Morin T, Martin JP, Feldmann G, et al. Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association. Lancet 1975;1:250-1.
4. Theodoropoulos G, Fertakis A, Archimandritis A, et al. Alpha 1-antitrypsin phenotypes in cirrhosis and hepatoma. Acta Hepatogastroenterol (Stuttg) 1976;23:114-7.
5. Vecchio FM, Fabiano A, Orsini G, et al. Alpha-1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults. Digestion 1983;27:100-4.
6. Eigenbrodt ML, McCashland TM, Dy RM, et al. Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease. Am J Gastroenterol 1997;92:602-7.
7. Fischer HP, Ortiz-Pallardo ME, Ko Y, et al. Chronic liver disease in heterozygous alpha1-antitrypsin deficiency PiZ. J Hepatol 2000;33:883-92.
8. Graziadei IW, Joseph JJ, Wiesner RH, et al. Increased risk of chronic liver failure in adults with heterozygous alpha 1-antitrypsin deficiency. Hepatology 1998;28:1058-63.
9. Hodges JR, Millward-Sadler GH, Barbatis C, et al. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 1981;304:557-60.
10. Carlson J, Eriksson S. Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody. Scand J Gastroenterol 1985;20:835-42.
11. Bell H, Schrumpf E, Fagerhol MK. Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease. Scand J Gastroenterol 1990;25:788-92.
12. Vennarecci G, Gunson BK, Ismail T, et al. Transplantation for end stage liver disease related to alpha 1 antitrypsin. Transplantation 1996;61:1488-95.
13. Bruce RM, Cohen BH, Diamond EL, et al. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects. Am Rev Respir Dis 1984;130:386-90.
14. Buist AS, Sexton GJ, Azzam AM, et al. Pulmonary function in heterozygotes for alpha,-antitrypsin deficiency: a case-control study. Am Rev Respir Dis 1979;120:759-66.
15. Gelb AF, Klein E, Lieberman J. Pulmonary function in non-smoking subjects with alphal antitrypsin deficiency (MZ phenotype). Am J Med 1977;62:93-8.
16. Horton FO III, Mackenthun AV, Anderson PS Jr, et al. Alpha 1 antitrypsin heterozygotes (Pi type MZ). A longitudinal study of the risk of development of chronic air flow limitation. Chest 1980;77(Suppl 2):261-4.
17. Morse JO, Lebowitz MD, Knudson RJ, et al. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N Engl J Med 1977;296:1190-4.
18. Brantly M. Laboratory Diagnosis of alpha-1 antitrypsin deficiency. In: Crystal R, ed. Alpha-1 Antitrypsin Deficiency. New York: Marcel Dekker Inc, 1995:45-60.
19. Brantly M. Alpha-1 antirtyupsin phenotypes and genotypes. In: Crystal R, ed. Alpha-1 Antitrypsin Deficiency. New York: Marcel Dekker Inc, 1995:211-26.
20. Brantly ML, Wittes JT, Vogelmeier CF, et al. Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes. Chest 1991;100:703-8.
21. American Thoracic Society/European Respiratory Society Statement. Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. Am J Respir Crit Care Med 2003;168:818-900.
22. de Serres FJ. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 2002;122:1818-29.
23. Tarjan E, Magyar P, Vaczi Z, et al. Longitudinal lung function study in heterozygous PiMZ phenotype subjects. Eur Respir J 1994;7:2199-204.
24. Klayton R, Fallat R, Cohen AB. Determinants of chronic obstructive pulmonary disease in patients with intermediate levels of alpha-antitrypsin. Am Rev Respir Dis 1975;112:71-5.
25. Sandford AJ, Weir TD, Spinelli JJ, et al. Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 1999;20:287-91.